Skip to content

Dietary Factors Associated to Colorectal Premalignant Lesions (COLOMAR-1)

Dietary Factors Associated to Colorectal Premalignant Lesions (COLOMAR-1)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06368661
Enrollment
30
Registered
2024-04-16
Start date
2023-09-01
Completion date
2024-12-31
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutrition Related Neoplasm/Cancer

Keywords

Fish, Colon cancer, Rectal cancer

Brief summary

This study aims to find a correlation between fish protein intake and other dietary habits and colorectal premalignant lesions in healthy volunteers. It also aims to describe gut microbial profiles for each dietary pattern, in order to elucidate the role of fish intake in cancer prevention.

Detailed description

Colorectal cancer incidence is increasing in developed countries specially among young adults due to risk factors as modern dietary, smoking, low physical exercise and obesity. Some foods (fruits, vegetables, nuts, other seeds and legumes) are assumed to prevent occurrence of colorectal cancer, while red and processed meat intake are strongly associated with increased risk of colorectal tumors. However, evidence on fish intake is still scarce, and the mechanisms and drivers of their potential health benefits are also only partially known. On the other hand, colonoscopy remains the gold standard for colon cancer screening. Our study aims to explore the relationship among fish intake, microbiota and molecular alterations during a colonoscopy screening program of healthy volunteers. This is a preliminary proof-of-concept study (ColoMAR-1) to evaluate the feasibility of the entire research program (ColoMAR-2). The main objectives of this pilot are: 1. To determinate the feasibility of the entire research project obtaining data for all the study participants (colonoscopy, blood sample, feces sample and dietary questionnaire). 2. To evaluate the presence of precancerous lesions (colonic polyps) and colorectal malignant tumors in all the participants. 3. To find molecular alterations (Alkylating signature) in normal mucosa of right and left-sided colon samples. 4. To describe microbiota composition in all the participants. 5. To determinate correlation between dietary habits and clinical and molecular findings of the study. 6. To calculate the overall sample size of the entire research program (ColoMAR-2) in base to dietary patterns and Alkylating signature prevalence of the participants)

Interventions

None listed

Sponsors

CEU San Pablo University
CollaboratorOTHER
Fundación Vithas
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 45 years old or more. * Be willing to participate in the study.

Exclusion criteria

* Pregnancy * Previous colorectal cancer. * Familial colorectal cancer syndrome. * Previous colonoscopy and colon polypectomy (last five years ). * Inflammatory bowel disease. * Medical contraindication for colonoscopy at investigator´s criteria.

Design outcomes

Primary

MeasureTime frameDescription
Dietary habits registry from participants: the dietary intakeDietary habits will be taken by an online specific Food Frequency Questionnaire (FFQ) for Spanish population. The data analysis will be taken at baseline outcome. 3 monthsDietary habits will be taken by an online specific Food Frequency Questionnaire (FFQ) for Spanish population. The data analysis will be taken at baseline outcome.
Biomarkers in colon mucosa, precancerous lesions and colorectal cancer3 monthsAlkylating signature will be determined in normal mucosa of right and left colon, premalignant lesions and colorectal cancer
Gut microbiota profile4 monthsDifferences in profile of gut microbiota among participants with and without precancerous lesions and colorectal cancer will be evaluated. Differences in profile of gut microbiota among different profiles of dietary habits will be evaluated.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026